Results 241 to 250 of about 136,011 (340)

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme [PDF]

, 2007
James J. Vredenburgh, Annick Desjardins, James E. Herndon, Jennifer Marcello, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, John H. Sampson, Melissa Wagner, Leighann Bailey, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman   +14 more
openalex   +1 more source

Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer [PDF]

, 2007
Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey A. Douglas, Robert A. Burger, Deborah K. Armstrong, Robert M. Wenham, William P. McGuire   +10 more
openalex   +1 more source

Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To examine long‐term visual impairment and visual field examination (VF) after diverse treatments for paediatric optic pathway glioma (OPG), and to determine prognostic factors for long‐term severe visual impairment or blindness. Methods A nationwide retrospective cohort study (1995–2018) was performed on paediatric OPGs that received ...
C. A. M. Bennebroek, J. van Zwol, M. C. Montauban van Swijndregt, S. E. Loudon, A. L. W. Groot, N. J. C. Bauer, J. W. Pott, I. C. Notting, A. J. van Sorge, M. M. van Genderen, P. de Graaf, A. Y. N. Schouten‐van Meeteren, P. Saeed, G. L. Porro   +13 more
wiley   +1 more source

Press Release: Chemotherapy with Bevacizumab Increases Risk of Blood Clots in Arteries [PDF]

, 2007
L. Savage, Andrea Widener
openalex   +1 more source

Intravitreal bevacizumab

Indian Journal of Ophthalmology, 2018
openaire   +3 more sources

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis

Acta Ophthalmologica, EarlyView.
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler, Andreas Arnold‐Vangsted, Marianne G. Schou, Rodrigo Anguita, Jakob Bjerager, Enrico Borrelli, Lasse J. Cehofski, Lorenzo Ferro Desideri, Elon H. C. van Dijk, Carsten Faber, Jakob Grauslund, Javad N. Hajari, Josef Huemer, Oliver N. Klefter, Marie Krogh Nielsen, M. Cem Sabaner, Miklos Schneider, Yousif Subhi   +17 more
wiley   +1 more source

Bevacizumab-Induced Cardiovascular Events: A Consequence of Cholesterol Emboli Syndrome? [PDF]

, 2007
Olivier Mir, Luc Mouthon, Jérôme Alexandre, Jean‐Michel Mallion, Gilbert Deray, Loı̈c Guillevin, François Goldwasser   +6 more
openalex   +1 more source

Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort

Alimentary Pharmacology &Therapeutics, EarlyView.
The approval of atezolizumab plus bevacizumab has improved first‐line therapy for advanced hepatocellular carcinoma, but the optimal sequencing of subsequent treatments remains uncertain. This real‐world study of 124 patients shows that only a minority advance to second‐ and third‐line therapies, with a progressive decline in liver function over ...
Najib Ben Khaled, Valentina Zarka, Bernard Hobeika, Julia Schneider, Monika Rau, Alexander Weich, Hans Benno Leicht, Liangtao Ye, Ignazio Piseddu, Michael T. Dill, Arne Kandulski, Matthias Pinter, Ursula Ehmer, Peter Schirmacher, Jens U. Marquardt, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter   +18 more
wiley   +1 more source

Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection [PDF]

, 2007
Fábio Bom Aggio, Michel Eid Farah, Gustavo Barreto Melo, Pedro Alves d’Azevedo, Antônio Carlos Campos Pignatari, Ana Luísa Hofling‐Lima   +5 more
openalex   +1 more source

Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response

British Journal of Clinical Pharmacology, EarlyView.
Pharmacokinetics plays a central role in understanding the significant interindividual differences that exist in drug metabolism and response. Effectively addressing these differences requires a multi‐faceted approach that encompasses a variety of tools and methods.
Magnus Ingelman‐Sundberg, Espen Molden
wiley   +1 more source